Recent publication from our research group reporting EMT changes and effects of ICS in the lungs of patients with asthma-COPD overlap (ACO) @Sohal_LabRTRG
https://t.co/qRuK1grxXl
Sharing some insights in the @ATSBlueEditor from our recent work on vascular / arterial pruning in smokers, and patients with early COPD. Similar pathology was evident in asthma-COPD overlap patients. EndMT seems central to destructive vascular pathology.
https://t.co/azS9Cf6kF8
Pleased to share our Special Report discussing Pathophysiology of small airways in idiopathic pulmonary fibrosis (IPF): the silent zone @Monica_w_LU @Sohal_LabRTRG #IPF#airways https://t.co/4KCU0e4Fn7
Congrats to our own Dr Sukhwinder Sohal @Romy_Sohal who was recognised at the recent European Respiratory Society Congress for his extensive research work into lung health. Dr Sohal was joined by Dr Monica Lu @Monica_w_LU who presented three papers at the Congress 👏
In this @Sohal_LabRTRG research article, Bhattarai et al. investigate the roles of drivers of endothelial to mesenchymal transition, uncovering an active endothelial SMAD pathway, independent of TGF-β1 in smokers, SAD, and COPD patients. #ClinSci#Smoking
https://t.co/7TnBZQuBis
Nice to see our recent work making to cover of the Clinical Science! Very thankful to the Journal and Editors for recognizing the importance of this work in #COPD - https://t.co/vhLV1aOU1w
Recent work from our research group reporting endothelial TGFβ1, pSMAD2/3, SAMD7 and β-catenin in pulmonary arteries from smokers and COPD informing EndMT. Endothelial SMAD pathway is independent of TGF-β1 in smokers and COPD. https://t.co/HuU1ScndM3 @bhprem03@Monica_w_LU
Recent work from our research group reporting endothelial TGFβ1, pSMAD2/3, SAMD7 and β-catenin in pulmonary arteries from smokers and COPD informing EndMT. Endothelial SMAD pathway is independent of TGF-β1 in smokers and COPD. https://t.co/HuU1ScndM3 @bhprem03@Monica_w_LU
Many congratulations and well done to our PhD student @bhprem03, who is now Dr Bhattarai 😊. Prems research reported the novel process of EndMT and its contribution to pulmonary arterial remodelling in smokers, patients with small airway disease and early COPD @Monica_w_LU
Large airway wall lamina propria in patients with asthma–COPD overlap is hypovascular with an increase in reticular basement membrane neoangiogenesis, reflecting smoking-related COPD-like pathology and potential epithelial-to-mesenchymal transition https://t.co/t43MeXP6c0 @deys79
Delighted to see our recent work on differential expression of mast cells in smokers, patients with small #airway disease and early #COPD highlighted on ERJ Open’s front page. Thanks very much @ERSpublications https://t.co/CBzsPrFe0a @matsuji2013@Monica_w_LU@Sohal_LabRTRG
Do not agree with EMT in asthma, no human tissue evidence, in fact negative with no core tissue structural Rbm fragmentation as key to EMT. Evidence is more in vitro in asthma (produced). EMT is central to COPD as evident from empiric human tissue work & further confirmed 😊
Truely honoured to have become a Fellow of the @tsanz_thoracic The Fellow status is a mark of distinction, conferring recognition on members for their outstanding contributions to the Society as well as to the fields of pulmonary, critical care, and sleep medicine #tsanzasm2024
Airway wall lamina propria in patients with Asthma-COPD Overlap (ACO) is hypo-vascular with increase in reticular basement membrane neo-angiogenesis, reflecting smoking-related COPD like pathology and EMT. https://t.co/9dS2nfUTIU
Mast cells in smokers and patients with small airway disease and COPD may be associated with airway wall changes and impaired lung function, indicating an active role in maintaining normal tissue homeostasis and, indirectly, in airway architecture https://t.co/mJAyCSPHCT
Pleased to share recent work from our research group reporting TGF-β1, pSmad-2/3, Smad-7, and β-Catenin signalling pathways in the pulmonary arteries from patients IPF and their potential role in driving EndMT.
Link to paper - https://t.co/cdnUiaIfsh